ePrints

A Randomized Controlled Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

Lookup NU author(s): Professor Pierre Bedossa, Professor Quentin AnsteeORCiD

Downloads

• Accepted version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum S, Francque S, Charlton M, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V

Publication type: Article

Publication status: Published

Journal: New England Journal of Medicine

Year: 2024

Volume: 390

Issue: 6

Pages: 497-509

Print publication date: 08/02/2024

Online publication date: 08/02/2024

Acceptance date: 15/12/2023

Date deposited: 14/06/2024

ISSN (print): 0028-4793

ISSN (electronic): 1533-4406

Publisher: Massachusetts Medical Society

URL: https://doi.org/10.1056/NEJMoa2309000

DOI: 10.1056/NEJMoa2309000

ePrints DOI: 10.57711/nt0h-4e68

Data Access Statement: A data sharing statement provided by the authors is available with the full text of this article at NEJM.org.

Altmetrics

Share